Tilray Inc. (TLRY)

108.84
6.50 6.40
NASDAQ : Health Technology
Prev Close 102.34
Open 101.02
Day Low/High 100.50 / 113.85
52 Wk Low/High 20.10 / 300.00
Volume 1.49M
Avg Volume 8.35M
Exchange NASDAQ
Shares Outstanding 76.48M
Market Cap 10.57B
EPS -0.10
Div & Yield N.A. (N.A)

Latest News

The Honeymoon Is Over for Cannabis Stocks

The Honeymoon Is Over for Cannabis Stocks

Shares of Tilray, Canopy Growth and Aurora Cannabis are down sharply on Wednesday.

Here's 2 Portfolio Names Whose Weakness Offers Opportunity

The portfolio will be taking these actions on Wednesday afternoon for VirTra and Aurora Cannabis.

Canopy Growth Slides After Quarterly Revenue Misses Estimates

Canopy Growth Slides After Quarterly Revenue Misses Estimates

Canopy Growth's fiscal second-quarter revenue misses analysts' estimates.

Tilray Slips as Revenue Misses and EPS Is a Little Better Than Estimates

Tilray Slips as Revenue Misses and EPS Is a Little Better Than Estimates

Tilray shares are falling after reporting mixed third-quarter results.

Cisco, Macy's, Boeing, Tilray and Snap - 5 Things You Must Know

Cisco, Macy's, Boeing, Tilray and Snap - 5 Things You Must Know

U.S. stock futures are mixed on Wednesday and global stocks trade mostly lower amid global growth concerns; oil rebounds modestly after a record 12-day slide; Cisco and Macy's report earnings; the FAA begins a review of Boeing's safety analyses after the fatal Lion Air crash.

Tilray, Inc. Reports Third Quarter 2018 Earnings

Tilray, Inc. Reports Third Quarter 2018 Earnings

Tilray, Inc. ("Tilray" or the "Company") (NASDAQ: TLRY), a global leader in cannabis production and distribution, today reported financial results for the third quarter and nine months ended September 30, 2018.

Chart of the Day: Midterm Results Offer Hope to Cannabis Names Looking at U.S

Chart of the Day: Midterm Results Offer Hope to Cannabis Names Looking at U.S

Cannabis' strong shift on midterms offers hope for pot stocks to play in America.

This Isn't the Right Environment for a Momentum Play Like Tilray

This Isn't the Right Environment for a Momentum Play Like Tilray

If Tilray happens to gap up on earnings I expect it will be sold aggressively.

Tilray Is the Cannabis Wild Child Stock

Tilray Is the Cannabis Wild Child Stock

Citron's Andrew Left has maintained a short position throughout that would appear dangerous to most, yet he seems very confident.

Short-Sellers Stay Strong on Tilray Stock, Await January Judgment

Short-Sellers Stay Strong on Tilray Stock, Await January Judgment

Shorts aren't shying away from the cannabis industry even after a series of squeezes.

Here's Why Tilray Stock Is the Wild Child

Here's Why Tilray Stock Is the Wild Child

Perhaps the highest profile impact on Tilray equity performance has been the interest of Andrew Left of Citron Research.

Tilray's Bull Move Is Not Over: Think Long Term

Tilray's Bull Move Is Not Over: Think Long Term

Here's why I favor the upside in TLRY stock going forward.

Tilray Stock Higher Ahead of First Post-Legalization Earnings Release

Tilray Stock Higher Ahead of First Post-Legalization Earnings Release

Tilray will have a lot to tackle this evening.

How This Former VC Player Became CEO of $2 Billion Cannabis Company Tilray

How This Former VC Player Became CEO of $2 Billion Cannabis Company Tilray

With Tilray set to report earnings after today's closing bell, we're rewinding to our sit-down with CEO Brendan Kennedy.

This Strong U.S. Dollar Is Deadly: Market Recon

This Strong U.S. Dollar Is Deadly: Market Recon

The never-ending strength now seen in the dollar is causing the most pain in U.S. markets.

Your Game Plan: Cramer's 'Mad Money' Recap (Friday 11/9/18)

Your Game Plan: Cramer's 'Mad Money' Recap (Friday 11/9/18)

Jim Cramer says the Fed is overreacting and he isn't worried about oil prices. Here's your game plan for next week.

Jim Cramer Talks Take-Two and What's Next for Cannabis

Jim Cramer Talks Take-Two and What's Next for Cannabis

Jim Cramer takes a look at video game stocks, the cannabis craze and answers a question from a viewer.

Focus on FOMC After Rip-Roaring Day for Stocks: Market Recon

Focus on FOMC After Rip-Roaring Day for Stocks: Market Recon

Consumer Discretionary stocks were the hottest on Wednesday, though all eleven sectors easily finished in the green.

IGC, Tilray and Other Pot Stocks Gain After Sessions Quits as Attorney General

IGC, Tilray and Other Pot Stocks Gain After Sessions Quits as Attorney General

IGC and Tilray rise by double-digit percentages and other weed stocks rally as anti-pot attorney general steps down and voters back cannabis sales in three states.

Pot Stocks Pop After Michigan Legalizes Recreational Cannabis Use

Pot Stocks Pop After Michigan Legalizes Recreational Cannabis Use

Michigan becomes the 10th U.S. state to legalize the recreational use of marijuana.

Out-of-Stock Levels Are High for Recreational Cannabis in Canada

Out-of-Stock Levels Are High for Recreational Cannabis in Canada

An early look at the market shows supply is finding it tough to keep up with demand.

2 Groups to Watch as the Midterm Election Unfolds: Cannabis and Drug Stocks

2 Groups to Watch as the Midterm Election Unfolds: Cannabis and Drug Stocks

A bunch of pot stocks are in play on Tuesday -- for a reason.

Curaleaf Stock Stumbles as Multi-State Landscape Gets Crowded

Curaleaf Stock Stumbles as Multi-State Landscape Gets Crowded

The stock closed down on its first day of trading on the CSX. Here is a breakdown of the current landscape and some up-and-comers to keep an eye on.

Tilray, Inc. To Present At The Morgan Stanley Global Consumer And Retail Conference

Tilray, Inc. To Present At The Morgan Stanley Global Consumer And Retail Conference

Tilray, Inc. ("Tilray" or the "Company") (NASDAQ: TLRY), a global leader in cannabis production and distribution, today announced that Brendan Kennedy, President and Chief Executive Officer, and Mark Castaneda, Chief Financial Officer, Secretary and...

Tilray To Report Third Quarter 2018 Financial Results On November 13, 2018

Tilray To Report Third Quarter 2018 Financial Results On November 13, 2018

Tilray Inc. (Nasdaq: TLRY), a global leader in cannabis production and distribution, announced today it will report results for the third quarter ended September 30, 2018 on Tuesday, November 13, 2018 after market close.

Rick Simpson Oil (RSO): Benefits, Effects and Research in 2018

Rick Simpson Oil (RSO): Benefits, Effects and Research in 2018

Rick Simpson oil (RSO) is a form of concentrated cannabis oil often used to treat diseases and cancer, and was popularized by marijuana activist Rick Simpson.

Tilray, Aurora and Other Cannabis Stocks Get Burned on Monday

Tilray, Aurora and Other Cannabis Stocks Get Burned on Monday

Cannabis stocks are facing steep declines on Monday.

Monday Madness: It's All About Cannabis and Chip Stocks

Monday Madness: It's All About Cannabis and Chip Stocks

Here's what you're missing on TheStreet.